Last reviewed · How we verify

Safety and Efficacy of Tazarotene Cream 0.1% Compared With Adapalene Gel 0.3% in the Treatment of Moderate to Severe Facial Acne Vulgaris

NCT00829049 Phase 4 TERMINATED Results posted

Comparison of the safety and efficacy of Tazarotene Cream 0.1% compared with Adapalene Gel 0.3% in treating moderate to severe facial acne vulgaris

Details

Lead sponsorAllergan
PhasePhase 4
StatusTERMINATED
Enrolment165
Start date2007-10
Completion2008-10

Conditions

Interventions

Primary outcomes

Countries

United States